Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +55.72%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Pump.fun Pump.fun +19.14%
#10 Unit Pump Unit Pump +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rankning i aktier #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Aktiekurs
$0.12164306
Senast synkroniserad: 2024-11-11
Marknadsvärde
$38.53M
Förändring (1 dag)
-4.14%
Förändring (1 år)
0.00%
Land
AU
Handel PharmAust Limited (PAA)

Kategori

Healthcare
P/B-tal för PharmAust Limited (PAA)
P/B-tal per August 2026 TTM: 8.34
Enligt PharmAust Limited senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 8.34. I slutet av 2024 hade företaget ett P/B-tal på 7.07.
Historik för P/B-tal för PharmAust Limited från 2001 till 2026
P/B-tal vid årets slut
År P/B-tal Ändra
2026 (TTM) 8.34 -66.96%
2025 25.24 257.09%
2024 7.07 14.20%
2023 6.19 118.92%
2022 2.83 -12.60%
2021 3.24 -39.88%
2020 5.38 357.35%
2019 1.18 54.04%
2018 0.76 -23.38%
2017 1.00 -25.35%
2016 1.34 27.23%
2015 1.05 -36.35%
2014 1.65 -90.55%
2013 17.45 671.52%
2012 2.26 -68.36%
2011 7.15 99.09%
2010 3.59 333.85%
2009 0.83 5.81%
2008 0.78 -13.33%
2007 0.90 -33.57%
2006 1.36 -44.16%
2005 2.43 -64.38%
2004 6.83 667.26%
2003 0.89 -50.23%
2002 1.79 19.65%
2001 1.49 0.00%
P/B-tal för liknande företag eller konkurrenter
Företag P/B-tal Skillnad i P/B-tal Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -23.94%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -25.15%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -69.95%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -55.52%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH